#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 31 '26)

 

Arch Virol

1. GUDYMO AS, Kolosova NP, Panova AS, Shadrinova KN, et al
   Contact transmission of fur seal-derived genotype A3 influenza A(H5N1) virus in ferrets.
   Arch Virol. 2026;171:313.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

2. KONSTANTOPOULOU A, Velali K, Markopoulou P, Anastasiadou A, et al
   Impact of national RSV immunization programme on the epidemiology of bronchiolitis in Greece.
   Epidemiol Infect. 2026;154:e143.
   PubMed         Abstract available
   
   
3. HAYES B, Lamielle G, Moon M, Padungtod P, et al
   Effectiveness of live-animal and environmental samples for detecting high pathogenicity avian influenza viruses in live-bird markets in Southeast Asia, 2015-2022.
   Epidemiol Infect. 2026 Oct 28:1-24. doi: 10.1017/S0950268826102246.
   PubMed        
   
   
4. PLANCHAND S, Nivoix C, Fischer EAJ, Vergne T, et al
   Divide and reduce: systematic review and mathematical modelling of the impact of within-farm compartmentalisation on avian influenza transmission in poultry.
   Epidemiol Infect. 2026 Oct 27:1-30. doi: 10.1017/S0950268826102350.
   PubMed        
   
   
5. SCOTT M, Browning L, Roberts T, De Boer J, et al
   An investigation into post-pandemic ethnic group and deprivation inequalities in influenza and COVID-19 hospitalizations.
   Epidemiol Infect. 2026;154:e139.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

6. SHU B, Liddell J, Wong P, Duron ES, et al
   Update to the CDC influenza A(H3) subtyping assay for improved detection of influenza A(H3N2) viruses, including subclade K viruses.
   J Clin Microbiol. 2026 Oct 27:e0072726. doi: 10.1128/jcm.00727.
   PubMed         Abstract available
   
   

   
   J Immunol

7. CHANG LA, Burgess E, Noureddine M, Wells AJ, et al
   Vaccine immunity can drive eosinophil recruitment in influenza breakthrough infection with mouse strain-specific outcomes.
   J Immunol. 2026;215:vkag279.
   PubMed         Abstract available
   
   

   
   J Virol

8. FARRUKEE R, Xia Y, Morris R, Barnes JB, et al
   Bovine myxovirus resistance protein (Mx)1, but not Mx2, mediates antiviral activity against human and avian influenza A viruses, including H5N1 clade 2.3.4.4b.
   J Virol. 2026 Oct 28:e0137226. doi: 10.1128/jvi.01372.
   PubMed         Abstract available
   
   

   
   PLoS One

9. ABDOLLAHI K, Rezaei Ghahroodi Z, Mansourian M
   Causal discovery and inference in COVID-19: A multiscale longitudinal analysis using mixtures of DAGs.
   PLoS One. 2026;21:e0355553.
   PubMed         Abstract available
   
   
10. ZHANG L, Ton B, Mewton L, Schweizer S, et al
    Alcohol use and its associations with mental health across the first year of the COVID-19 pandemic.
    PLoS One. 2026;21:e0361854.
    PubMed         Abstract available
    
    
11. TIAN Y, Richards DK, Cox MJ
    Temporal and seasonal trends in public interest in nonalcoholic beverages and lifestyles: A Google Trends analysis, 2004-2026.
    PLoS One. 2026;21:e0361032.
    PubMed         Abstract available
    
    
12. BHUIYAN MRI, Sayem MA, Makhdum N
    Understanding the influencing factors of telemedicine service adoption in post-pandemic Bangladesh: An extended TAM and UTAUT2 model analysis.
    PLoS One. 2026;21:e0361691.
    PubMed         Abstract available
    
    
13. STENGLER AL, Mattern E, Ronellenfitsch U, Steckelberg A, et al
    Experiences and challenges of healthcare professionals in oncological surgery during the COVID-19 pandemic: A qualitative study.
    PLoS One. 2026;21:e0361492.
    PubMed         Abstract available
    
    
14. INUSAH AS, Xia H, Pasha A, Li Z, et al
    Longitudinal changes in BMI and obesity across COVID-19 pandemic periods among underrepresented populations: An analysis of the All of Us dataset.
    PLoS One. 2026;21:e0360745.
    PubMed         Abstract available
    
    
15. HABIB MI, Sayeed MA, Islam M, Sarker MFR, et al
    Epidemiological characterization of avian influenza virus circulation in pigeons and quail across different production systems in Chattogram, Bangladesh.
    PLoS One. 2026;21:e0361561.
    PubMed         Abstract available
    
    
16. MORITA T, Elsayed AMA, Hirakawa R, Lawal-Ayinde BM, et al
    Impact of low temperature on the efficacy of chlorous acid water and sodium hypochlorite solution for inactivating avian influenza virus on material surfaces.
    PLoS One. 2026;21:e0360392.
    PubMed         Abstract available
    
    
17. GARCES-ARILLA S, Fidalgo C, Mendez-Lopez M, Hidalgo V, et al
    Health-related quality of life in women and men with long COVID.
    PLoS One. 2026;21:e0357749.
    PubMed         Abstract available
    
    
18. SIMKHADA P, Lwin KS, Koirala B, Shrestha A, et al
    Barriers and facilitators of evidence-informed health policymaking in Nepal: A scoping review.
    PLoS One. 2026;21:e0358730.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. TURELLI P, Eray E, Raclot C, Trono D, et al
    Antigenic landscape of a highly mutated SARS-CoV-2 spike in ongoing viral evolution.
    Proc Natl Acad Sci U S A. 2026;123:e2608185123.
    PubMed         Abstract available
    
    
20. NILFOROSHAN H, Reisler J, Jahanparast E, Moor M, et al
    Revised estimates of types and duration of long COVID symptoms based on claims records from 245 million US patients.
    Proc Natl Acad Sci U S A. 2026;123:e2604414123.
    PubMed         Abstract available
    
    

    
    Vaccine

21. HUMBLE RM, Reifferscheid L, Gilbert NL, Dube E, et al
    Differences between Canadian parents' attitudes toward routine, influenza, and COVID-19 vaccines for their children, and changes in vaccine hesitancy since the pandemic: A national cross-sectional comparative study.
    Vaccine. 2026;96:129300.
    PubMed         Abstract available
    
    
22. ZHANG J, Shen Y, Shi W, Ma J, et al
    End-of-season influenza vaccine effectiveness against a(H3N2) and B/Victoria in Beijing, China, 2025/26 season.
    Vaccine. 2026;96:129273.
    PubMed         Abstract available
    
    
23. CHENG C, Chen X, Ge Y, Sung MH, et al
    Faster waning of immunity to influenza vaccine strains reintroduced into subsequent seasons: A human cohort study.
    Vaccine. 2026;95:129258.
    PubMed         Abstract available
    
    
24. MISHIN VP, Patel MC, Gao R, Grant L, et al
    Hemagglutinin- and neuraminidase-targeting antibody responses after receipt of egg-based inactivated or recombinant influenza vaccines among adults aged 18-64?years.
    Vaccine. 2026;95:129281.
    PubMed         Abstract available
    
    
25. CAI Z, Wang L, Ji S, Deng X, et al
    Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design.
    Vaccine. 2026;94:129265.
    PubMed         Abstract available
    
    
26. YAMAMOTO S, Matsuda K, Maeda K, Mizoue T, et al
    Protection of Omicron XBB.1.5 vaccine, previous infection, and their induced neutralizing antibodies against symptomatic SARS-CoV-2 infection during Omicron KP.3 wave.
    Vaccine. 2026;94:129242.
    PubMed         Abstract available
    
    
27. MENEZES APO, Leite JLP, Pimenta FC, Larson S, et al
    Pneumococcal carriage and selected respiratory virus in children with clinical pneumonia in Salvador, Brazil during PCV10 era.
    Vaccine. 2026;94:129241.
    PubMed         Abstract available
    
    
28. ISHII H, Miyauchi K, Harada S, Nakamura-Hoshi M, et al
    Intranasal immunization expressing S1 antigen can confer functionally sterile protection against an intranasal SARS-CoV-2 challenge in mice.
    Vaccine. 2026;94:129259.
    PubMed         Abstract available
    
    
29. MAYR W, Knell AI, Boehm AK, Jager M, et al
    Longitudinal SARS-CoV-2 mRNA vaccine immunogenicity in inflammatory bowel disease in relation to anti-TNF therapy and age: a prospective cohort study.
    Vaccine. 2026;94:129224.
    PubMed         Abstract available
    
    
30. MALIBWA D, Lees S, Ewing V, Deogratias D, et al
    Influence of COVID-19 and COVID-19 rumours on trust and uptake of single-dose male HPV vaccination in the Add-Vacc cluster-randomised trial, northwest Tanzania.
    Vaccine. 2026;94:129231.
    PubMed         Abstract available
    
    
31. TOME J, Schwind JS, Richmond HL, Deloach B, et al
    Vaccine recipient and volunteer experiences from COVID-19 mass vaccine clinics at a university campus: drive-through and walk-through approaches.
    Vaccine. 2026;94:129229.
    PubMed         Abstract available
    
    
32. PRASERT K, Nakphook S, Kittiwatanachod J, Ditsungneon D, et al
    Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 mug HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.
    Vaccine. 2026;94:129230.
    PubMed         Abstract available
    
    

    
    Virology

33. ARSANA A, Zhu W, Kang SM, Wang BZ, et al
    Towards influenza vaccine universality: Smart vaccine regimens and adjuvant-driven germinal center responses.
    Virology. 2026;625:111110.
    PubMed         Abstract available
    
    
34. SEGALIN JT, Weiss M, de Almeida G, Lenhard BF, et al
    Genotypic and phenotypic characterization of the main endemic swine influenza A virus subtypes in Brazil.
    Virology. 2026;625:111099.
    PubMed         Abstract available
    
    
35. ISAKOVA-SIVAK I, Matyushenko V, Rudenko L
    Influenza viruses as vaccine vectors: Historical background and future directions.
    Virology. 2026;625:111105.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 24 '26)

 

BMC Pediatr

1. PHUNG NTN, Tran TT, Van Nguyen N, Nguyen DH, et al
   Anticoagulation therapy in children with SARS-CoV-2 pneumonia: a retrospective observational study on dosage, efficacy, and safety.
   BMC Pediatr. 2026;26:1035.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

2. OWUSU-BOAITEY N, Meyer MJ, Herrera-Esposito D, Bottcher L, et al
   Estimating COVID-19 cumulative incidence from seroprevalence surveys accounting for time-varying seroreversion: A fully Bayesian methodology.
   Epidemiol Infect. 2026;154:e137.
   PubMed         Abstract available
   
   

   
   J Infect

3. PENG S, Deng Y, Liu J, Du X, et al
   From detection to prediction: Asymptomatic shedding-informed mass-balance modeling predicts travel-borne viral importation at airports.
   J Infect. 2026;93:106866.
   PubMed         Abstract available
   
   
4. BERES SB, Pagnossin D, Olsen RJ, Long SW, et al
   Clinical and population genomic epidemiology of invasive group A streptococcus in Scotland, 2014-2024.
   J Infect. 2026 Sep 18:106860. doi: 10.1016/j.jinf.2026.106860.
   PubMed         Abstract available
   
   
5. ORTEGA-FRANCISCO S, Prudente de Aquino MT, Chiuppesi F, Gutierrez-Franco MA Jr, et al
   Phase 2 evaluation of two GEO-CM04S1 dose levels shows comparable safety and broad immunogenicity.
   J Infect. 2026;93:106855.
   PubMed         Abstract available
   
   
6. WALKER JL, Ribeiro S, Litt D, Patel T, et al
   Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.
   J Infect. 2026;93:106836.
   PubMed         Abstract available
   
   

   
   J Virol

7. MEINEKE R, Knittler M-C, Tagore R, Engling N, et al
   Respiratory syncytial virus-induced ADAM17 activity controls maintenance of epithelial barrier integrity and promotes syncytium formation.
   J Virol. 2026;100:e0115026.
   PubMed         Abstract available
   
   
8. BUGA CC, Valerio M, Alenquer M, Pires de Miranda M, et al
   Insights into the mechanism of action of the bipartite fusion module of SARS-CoV-2 spike protein.
   J Virol. 2026 Sep 15:e0068826. doi: 10.1128/jvi.00688.
   PubMed         Abstract available
   
   
9. RODRIGUEZ GALVAN J, de Vries M, Belblidia S, Fisher A, et al
   Airway protease availability governs a reversible shift between syncytial and cell-free spread.
   J Virol. 2026;100:e0072726.
   PubMed         Abstract available
   
   
10. ALVARADO RE, Chen J, Lokugamage KG, Zhou Y, et al
    Antagonism of stress granules is key to SARS-CoV-2 infection and pathogenesis.
    J Virol. 2026 Sep 8:e0099226. doi: 10.1128/jvi.00992.
    PubMed         Abstract available
    
    

    
    PLoS One

11. FOOX Y, Yamin D, Chalutz-BenGal H, Ben-Gal I, et al
    Applying normalized p-control charts for early detection of local COVID-19 outbreaks.
    PLoS One. 2026;21:e0357183.
    PubMed         Abstract available
    
    
12. SONG A, Zuvia C, Talbot P
    Susceptibility of human neural stem cells to SARS-CoV-2: Entry mechanisms and glycocalyx influence.
    PLoS One. 2026;21:e0360734.
    PubMed         Abstract available
    
    
13. THOMAS C, Ashton RE, Pretorius E, Owen R, et al
    Blood biomarkers of long COVID: A cross-sectional evaluation of key cytokines and the coordination of inflammation.
    PLoS One. 2026;21:e0360525.
    PubMed         Abstract available
    
    
14. REDMAN WT, Mullany LC
    Data-driven forecasting of Flu, RSV, and COVID-19 related outcomes in the United States and Canada via Hankel dynamic mode decomposition.
    PLoS One. 2026;21:e0360068.
    PubMed         Abstract available
    
    
15. MAHMOOD B, Hu J, Tang TS, Adu P, et al
    Impact of the COVID-19 pandemic and control measures on type 2 diabetes care among South Asians: the perspective of healthcare providers in British Columbia, Canada.
    PLoS One. 2026;21:e0359295.
    PubMed         Abstract available
    
    
16. JUHASZ L, Garba NA, Moise IK, Bhoite PB, et al
    The detection paradox: How COVID-19 surveillance patterns shifted from lower-income to more affluent neighborhoods in Miami-Dade County.
    PLoS One. 2026;21:e0361211.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

17. HVID U, Nielsen BF, Sneppen K
    Bridging spatial scales in respiratory viral infection.
    Proc Natl Acad Sci U S A. 2026;123:e2614436123.
    PubMed         Abstract available
    
    

    
    Vaccine

18. KROKHIN A, Romanova J, Grillari R, Hackl M, et al
    AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication.
    Vaccine. 2026;94:129237.
    PubMed         Abstract available
    
    
19. XU S, Sy LS, Hong V, Farrington P, et al
    Ischemic stroke after bivalent mRNA COVID-19 vaccination and influenza vaccination during the 2022-2023 season: a multi-site self-controlled case series study.
    Vaccine. 2026;95:129263.
    PubMed         Abstract available
    
    

    
    Virology

20. RZYMSKI P, Malecka I, Szczepanska B, Wasielewska Z, et al
    RSV, influenza, and COVID-19 in hospitalized children: A comparative analysis of the 2025/2026 epidemic season in Poland.
    Virology. 2026;625:111104.
    PubMed         Abstract available
    

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 17 '26)

 

Epidemiol Infect

1. ONTAS E
   Establishing influenza epidemic thresholds and intensity levels in Turkiye using the moving epidemic method and assessing concordance with WHO transmission zones: A sentinel surveillance analysis of ten seasons, 2013-2025.
   Epidemiol Infect. 2026;154:e129.
   PubMed         Abstract available
   
   
2. KUMBAROFF Z, Harvey EP, Whitehead J, O'Neale DRJ, et al
   Ethnic inequities in mathematical models for respiratory infectious disease: A systematic review.
   Epidemiol Infect. 2026;154:e130.
   PubMed         Abstract available
   
   
3. HAUSER-VAN WESTRHENEN ESEM, De Hoog MLA, Winkel AMAM, Junquera Guinovart L, et al
   Viral interference with SARS-CoV-2 during the COVID-19 pandemic: An individual participant data meta-analysis.
   Epidemiol Infect. 2026;154:e128.
   PubMed         Abstract available
   
   
4. TRIGO F, Guillen JM, Hernandez-Barrera V, Gil R, et al
   Burden of RSV hospital disease and its comorbidities in adults in Spain (2016-2023).
   Epidemiol Infect. 2026;154:e127.
   PubMed         Abstract available
   
   
5. PILAPIL JD, Mata MA, Del Rosario R, Pasciolco MJ, et al
   Genomic surveillance of COVID-19 in Hong Kong (2020-2023): Analysing SARS-CoV-2 variants, mutations, and their impact on viral entry.
   Epidemiol Infect. 2026;154:e124.
   PubMed         Abstract available
   
   
6. SPRONK M, Boyd A, Campman SL, Jongen V, et al
   Presence of post-COVID-19 condition in six ethnic groups in Amsterdam, the Netherlands: a retrospectively reconstructed time interval approach.
   Epidemiol Infect. 2026;154:e121.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

7. HEIMSCH KC, Stanoeva KR, Visser I, Rahou Y, et al
   SARS-CoV-2 and RSV external quality assessment on molecular detection and variant typing in European expert laboratories in 2025.
   J Clin Microbiol. 2026;64:e0025826.
   PubMed         Abstract available
   
   
8. SMITH K, Martinez J, Yu H, Harrison J, et al
   Development and evaluation of an ARTIC-based amplicon sequencing assay for whole-genome characterization of respiratory syncytial virus.
   J Clin Microbiol. 2026;64:e0046826.
   PubMed         Abstract available
   
   

   
   J Immunol

9. KOUTSAKOS M, Crawford JC, Grzelak L, Rizzetto S, et al
   TCRalphabeta repertoire plasticity defines universal CD8+ T cell responses directed at influenza-specific HLA-A*02:01-PB1413-421 epitope.
   J Immunol. 2026;215:vkag270.
   PubMed         Abstract available
   
   

   
   J Infect Dis

10. BAI X, Chen S, Yin S, Zhao Q, et al
    Characterization of Mucosal BPI fold-containing family A member 1-High-Expressing Neutrophils and their Immune Defense roles in Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection via single-cell RNA sequencing.
    J Infect Dis. 2026;234:583-593.
    PubMed         Abstract available
    
    
11. NARAYAN K, Tosh K, Holmes A, Hu L, et al
    Serum Virus-Neutralizing Antibody Titers in Clinical Trial Participants With and Without Immunocompromise Receiving Pemivibart, a Long-Acting Monoclonal Antibody for COVID-19.
    J Infect Dis. 2026;234:e859-e868.
    PubMed         Abstract available
    
    
12. AVADHANULA V, Bournat J, Ferlic-Stark LL, Bond NL, et al
    Impact of Low Community Circulation of Respiratory Syncytial Virus (RSV) on Immunity Debt Against RSV in Adults During the Coronavirus Disease 2019 Pandemic.
    J Infect Dis. 2026;234:564-572.
    PubMed         Abstract available
    
    
13. SUTCLIFFE CG, Sergent VM, Yazzie D, Brasinikas G, et al
    Post-COVID Rebound in Invasive Pneumococcal Disease Driven by Resurgence of Serotype 4 Among American Indian Individuals in the Southwest United States.
    J Infect Dis. 2026;234:e908-e921.
    PubMed         Abstract available
    
    
14. MOORE HC, Foo D, Giannini F, Minney-Smith C, et al
    What is the Optimal RSV Immunization Strategy for Infants Born in the RSV Off-season?
    J Infect Dis. 2026;234:e823-e828.
    PubMed         Abstract available
    
    
15. EPSI NJ, Richard SA, Morris MJ, Lindholm DA, et al
    Is Cellular Senescence a Biological Feature of Long COVID? A Transcriptomic Analysis Across Comparative Postacute Sequelae Phenotypes.
    J Infect Dis. 2026;234:e869-e880.
    PubMed         Abstract available
    
    
16. PEREZ-GARCIA C, Llorente J, Aguirre Alastuey ME, Llamosi M, et al
    Lineage Dynamics and Risk Factors Underlying Serotype 4 Invasive Pneumococcal Disease in Spain.
    J Infect Dis. 2026;234:e922-e934.
    PubMed         Abstract available
    
    
17. WAN T, Lautenbach E, Mannathoko N, Mosepele M, et al
    Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.
    J Infect Dis. 2026 Jul 7:jiag342. doi: 10.1093.
    PubMed         Abstract available
    
    
18. LEIS AM, Han JH, Hough CL
    Beyond the Acute Illness: Three Myths About Viral Respiratory Infection.
    J Infect Dis. 2026;234:513-515.
    PubMed         Abstract available
    
    

    
    J Virol

19. WILLIAMS SL, Gygli SM, Bjorgen JC, Fan H, et al
    Avian influenza A virus polymerase gene leads to temperature-resistant genome replication.
    J Virol. 2026 Oct 13:e0097826. doi: 10.1128/jvi.00978.
    PubMed         Abstract available
    
    

    
    PLoS Biol

20. NIU C, Huang X, Yan Q, Liu B, et al
    R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation.
    PLoS Biol. 2026;24:e3003996.
    PubMed         Abstract available
    
    

    
    PLoS One

21. BHUKHAI K, Tanhuad N, Srimorkun P, Manopwisedjaroen S, et al
    Omicron SARS-CoV-2 shows NRP1-linked susceptibility in adipose-derived MSCs and alters primitive cord blood CD34(+) HSPCs.
    PLoS One. 2026;21:e0360439.
    PubMed         Abstract available
    
    
22. SADIQ M, Wasim B, Khatoon A, Kumar A, et al
    Whole-exome sequencing identifies a missense variant in the cytoskeletal gene SVIL implicating actin remodeling in COVID-19 severity in a Pakistani cohort.
    PLoS One. 2026;21:e0360429.
    PubMed         Abstract available
    
    
23. REZENDE LMT, Silva KVC, Cuadro A, Signes VM, et al
    Consequences of COVID-19 infection on educators' executive functions: A systematic review and meta-analysis protocol.
    PLoS One. 2026;21:e0350156.
    PubMed         Abstract available
    
    
24. LI X, Ding J, Zhang Y, Hu T, et al
    Measuring destination image dissonance: A compositional data analysis of cross-media representations in Sanya's Tourism.
    PLoS One. 2026;21:e0360383.
    PubMed         Abstract available
    
    
25. YANG Y, Juntila-Raymond C, Callear A, Smith M, et al
    Evaluation of pre-Omicron population immunity for SARS-CoV-2 in the Household Influenza Vaccine Evaluation (HIVE) cohort.
    PLoS One. 2026;21:e0360506.
    PubMed         Abstract available
    
    
26. VERFAILLIE SCJ, Verveen A, Visser D, Nieuwkerk P, et al
    Post-acute sequelae of COVID-19 (PASC) are associated with distinct clinical phenotypes two years after SARS-CoV-2 infection: A data-driven approach.
    PLoS One. 2026;21:e0359844.
    PubMed         Abstract available
    
    
27. NGAMALEU MR, Tene H, Djounda R, Minomo R, et al
    Early inflammation-driven damage and delayed viral clearance are associated with prolonged biliary perturbation in a Cameroonian cohort of COVID-19 patients.
    PLoS One. 2026;21:e0357503.
    PubMed         Abstract available
    
    
28. JUNG H, Jung M
    A retrospective epidemiological study of screening-derived solid cancer incidence proxy rates in South Korea before and after COVID-19 using Korean National Health Insurance Service data.
    PLoS One. 2026;21:e0360040.
    PubMed         Abstract available
    
    

    
    Vaccine

29. BOER M, Klugkist I, Kroese F
    Educational background and vaccination beliefs in the Netherlands: A Bayesian Evidence Synthesis from four studies.
    Vaccine. 2026;93:129132.
    PubMed         Abstract available
    
    
30. SAIKI S, Kuroiwa M, Hashimoto K, Nakajima-Yoshida H, et al
    LP.8.1-directed recombinant protein COVID-19 vaccine S-268025, formulated with squalene-based adjuvant A-910823, elicits robust immunogenicity and neutralizing breadth in mice.
    Vaccine. 2026;93:129177.
    PubMed         Abstract available
    
    
31. BAZARJAV P, Erdene-Ochir T, Sandagdorj A, Enkhtuvshin A, et al
    One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.
    Vaccine. 2026;93:129179.
    PubMed         Abstract available
    
    
32. GOULD S, Rohde CM, Destexhe E, Tiesjema B, et al
    Summary of 2025 Society of Toxicology Workshop "Vaccine Toxicology in the Post-COVID Era".
    Vaccine. 2026;93:129180.
    PubMed         Abstract available
    
    
33. BRADY C, Govender M, Mellors J, Tipton T, et al
    Spike antibody Fc is associated with protection from SARS-CoV-2 challenge in macaques.
    Vaccine. 2026;93:129192.
    PubMed         Abstract available
    
    
34. SHICHINOHE S, Li Q, Tanaka H, Anindita J, et al
    Cross-clade protection against human H5N1 isolates by a clade 2.3.4.4b HA mRNA vaccine in mice.
    Vaccine. 2026;93:129215.
    PubMed         Abstract available
    
    
35. BEOGO I, Xu Y, Kibret TC, Muray M, et al
    Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy.
    Vaccine. 2026;93:129214.
    PubMed         Abstract available
    
    
36. BEOGO I, Kibret TC, Zhang Q, Muray M, et al
    Ethnic disparities in COVID-19 vaccine uptake among among 55+ year-old Canadians: Exploring the role of racial discrimination, chronic disease comorbidities, and conspiracy beliefs.
    Vaccine. 2026;93:129213.
    PubMed         Abstract available
    
    
37. KOPP L, Hofner B, Mentzer D
    Mobile-app-based cohort event monitoring study (CEM) of COVID-19 vaccines.
    Vaccine. 2026;93:129219.
    PubMed         Abstract available
    
    
38. MARQUES DFP, Howard J, Alvarez ML, Machado A, et al
    Comparing two case definitions for including severe acute respiratory infection patients in influenza and COVID-19 vaccine effectiveness studies among older adults using the test-negative design: VEBIS hospital network, seven European countries, 2023/
    Vaccine. 2026;94:129234.
    PubMed         Abstract available
    

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 10 '26)

 

Antimicrob Agents Chemother

1. LIU S, Qiu X, Guo S, Wang L, et al
   Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.
   Antimicrob Agents Chemother. 2026;70:e0054126.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. APPEL S, Coughtrey AE, Kyrdalen A, Takeda A, et al
   Understanding heterogeneity in paediatric long COVID research: an overview of reviews and recommendations for future pandemics.
   BMC Pediatr. 2026;26:937.
   PubMed         Abstract available
   
   

   
   J Immunol

3. SEGARD A, Goguet E, Haines-Hull H, Williamson KC, et al
   Effects of natural killer cell depletion on innate and adaptive immune responses to COVID mRNA vaccination.
   J Immunol. 2026;215:vkag266.
   PubMed         Abstract available
   
   

   
   J Infect Dis

4. 
   Correction to: Introduction and Update: Advances in Influenza Therapeutics.
   J Infect Dis. 2026 Oct 8:jiag499. doi: 10.1093.
   PubMed        
   
   

   
   J Virol

5. CIACCI ZANELLA G, Vincent ML, Flores L, Aljets EK, et al
   A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine.
   J Virol. 2026 Oct 9:e0084826. doi: 10.1128/jvi.00848.
   PubMed         Abstract available
   
   
6. SOUZA CK, Santos JJS, Boggiatto P, Sterle H, et al
   H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves.
   J Virol. 2026 Oct 8:e0128926. doi: 10.1128/jvi.01289.
   PubMed         Abstract available
   
   
7. DEL ROSARIO JMM, van Diemen PM, Frost SDW, Vishwanath S, et al
   A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.
   J Virol. 2026 Oct 6:e0107326. doi: 10.1128/jvi.01073.
   PubMed         Abstract available
   
   
8. NOORUZZAMAN M, Buchholz DW, Rani R, de Oliveira PSB, et al
   Infection and transmission dynamics of bovine and human influenza A H5N1 viruses in mouse and hamster models.
   J Virol. 2026 Oct 6:e0104426. doi: 10.1128/jvi.01044.
   PubMed         Abstract available
   
   

   
   PLoS One

9. ZAIR X, Wilm A, Benton MC, Tham CY, et al
   Sub-consensus haploid variant calling in long-read sequencing technology.
   PLoS One. 2026;21:e0356259.
   PubMed         Abstract available
   
   
10. RAMIREZ-SOTO MC, Arroyo-Hernandez H, Machuca JVB, Stalder DH, et al
    Pneumonia incidence, hospitalizations and mortality before and during the COVID-19 pandemic in Peru: An observational study.
    PLoS One. 2026;21:e0351171.
    PubMed         Abstract available
    
    
11. YEO D, Woo S, Kim J, Kim K, et al
    Exposure to residential greenness and subsequent risk of common mental disorders among individuals with COVID-19 in South Korea: A nationwide cohort study.
    PLoS One. 2026;21:e0359016.
    PubMed         Abstract available
    
    
12. ANGRISANI M, Atella V, Bruine de Bruin W, Kopinska J, et al
    How personality traits shape susceptibility to mental distress in times of crisis: Evidence from the COVID-19 pandemic.
    PLoS One. 2026;21:e0358371.
    PubMed         Abstract available
    
    
13. PENG Q, Wu M, Feng Q
    Service-oriented reallocation and value-added intensity in China's sport industry, 2018-2024: A longitudinal accounting analysis.
    PLoS One. 2026;21:e0354049.
    PubMed         Abstract available
    
    
14. POQUET D, Le Gal C, Hincker P, Beghin L, et al
    Reach and engagement in the ECAIL trial targeting socially disadvantaged families across the COVID-19 pandemic and cost-of-living crisis: A mixed-methods implementation study.
    PLoS One. 2026;21:e0350372.
    PubMed         Abstract available
    
    
15. KANMA-OKAFOR OJ, Ravi P, Ngaybe MGB, Yusoof K, et al
    Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol.
    PLoS One. 2026;21:e0358599.
    PubMed         Abstract available
    
    
16. MYAT KYAW HM, Li Y, Chan DKC, Capio CM, et al
    COVID-19 infection and Hong Kong elementary children's Chinese and English reading proficiencies: Parent-reported proficiency versus performance-based reading tests.
    PLoS One. 2026;21:e0359793.
    PubMed         Abstract available
    
    
17. GUMMER T, Lu KH, von Glasenapp K
    Assessing the FAIRness of survey data collected during the COVID-19 pandemic in Germany.
    PLoS One. 2026;21:e0358755.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. ALSTON H, Mora T, Walczak AM
    Neutralization titers reveal the structure of polyclonal antibody responses.
    Proc Natl Acad Sci U S A. 2026;123:e2612096123.
    PubMed         Abstract available
    
    

    
    Vaccine

19. JEONG O, Kim PK, Oh H, Lee K, et al
    Sequence-Aware Antigenic Alignment and SRID Potency Interpretation in Influenza Vaccines.
    Vaccine. 2026;93:129191.
    PubMed         Abstract available
    

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 3 '23)

 

Antiviral Res

1. MA S, Chen Y, Zhu J, Zong Y, et al
   N70S/Y155H Combined Mutation of Neuraminidase of Avian Influenza H9N2 Virus confers oseltamivir and zanamivir resistance and pathogenicity to Mice.
   Antiviral Res. 2026 Sep 29:106540. doi: 10.1016/j.antiviral.2026.106540.
   PubMed         Abstract available
   
   

   
   J Infect

2. NAZARETH J, Martin CA, Pan D, Barr IG, et al
   Ethnic differences in inactivated influenza vaccine immunogenicity in UK Healthcare Workers: A two-year prospective longitudinal study.
   J Infect. 2026 Sep 29:106862. doi: 10.1016/j.jinf.2026.106862.
   PubMed         Abstract available
   
   
3. DUAN Q, Jin X, Fu X, Zhu A, et al
   Household transmission dynamics of human respiratory syncytial virus in China: A multicentre epidemiological and molecular study.
   J Infect. 2026;93:106834.
   PubMed         Abstract available
   
   
4. ZHOU S, Liu C, Liu W, Cai K, et al
   Cross-Neutralizing Antibody Responses to Diverse Coronaviruses in the Human Population.
   J Infect. 2026 Aug 11:106827. doi: 10.1016/j.jinf.2026.106827.
   PubMed         Abstract available
   
   
5. LI X, Mercade-Besora N, Lam AS, Barboza C, et al
   Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths.
   J Infect. 2026 Aug 5:106825. doi: 10.1016/j.jinf.2026.106825.
   PubMed         Abstract available
   
   
6. QUINOT C, Lunt R, Kirsebom F, Andrews N, et al
   Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England.
   J Infect. 2026;93:106819.
   PubMed         Abstract available
   
   

   
   MMWR Morb Mortal Wkly Rep

7. KYAW NTT, Foote MMK, Lo Piccolo AJ, Wallach AB, et al
   Unannounced Drills Using Patient Actors to Evaluate Health Care Facility Readiness for Infectious Disease Outbreaks - New Jersey, New York, and U.S. Virgin Islands, January-June 2026.
   MMWR Morb Mortal Wkly Rep. 2026;75:581-587.
   PubMed         Abstract available
   
   

   
   Pediatrics

8. FRINTNER MP, Freed GL, Byrne BJ, Gottschlich EA, et al
   Pediatrician Burnout Over Time: 2021-2025.
   Pediatrics. 2026;158:e2026076643.
   PubMed         Abstract available
   
   

   
   PLoS Biol

9. DAILEY KE, Wang Y, Teo QW, Wang C, et al
   Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody.
   PLoS Biol. 2026;24:e3004021.
   PubMed         Abstract available
   
   

   
   PLoS Comput Biol

10. LEMAITRE J, Lessler J
    Generative diffusion models for spatiotemporal influenza forecasting.
    PLoS Comput Biol. 2026;22:e1014846.
    PubMed         Abstract available
    
    

    
    PLoS One

11. LI Q, Bond RM, Nisbet E, Dixon G, et al
    The limited effects of social media use on misperceptions Social media's limited role in misperceptions.
    PLoS One. 2026;21:e0354486.
    PubMed         Abstract available
    
    
12. RICO-BOLIVAR DL, Diaz-Brochero C, Hattemer R, Bejarano-Mora CA, et al
    Causes of hospitalization among people living with HIV in a tertiary-care hospital in Bogota, Colombia, 2018-2024.
    PLoS One. 2026;21:e0357788.
    PubMed         Abstract available
    
    
13. DUCHOWNY K, Wang V, Noppert G, Melendez R, et al
    Essential work, unequal places: Neighborhood characteristics of the essential workforce in the United States during the COVID-19 pandemic.
    PLoS One. 2026;21:e0357792.
    PubMed         Abstract available
    
    
14. DE ANDA-JAUREGUI G, Sifuentes-Osornio J, Angulo-Guerrero O, Diaz-De-Leon-Santiago JL, et al
    Complexity of hospital demand during the COVID-19 pandemic in Mexico City.
    PLoS One. 2026;21:e0358798.
    PubMed         Abstract available
    
    
15. NEVES RKAD, Bastos LS, Maciel Villela DA, Saraceni V, et al
    Rehospitalization due to COVID-19 reinfection in Rio de Janeiro, 2020-2022: Associations with vaccination status, sociodemographic and clinical factors.
    PLoS One. 2026;21:e0332281.
    PubMed         Abstract available
    
    
16. BABAZADEH SHAREH M, Kleiner F, Bohme M, Hagele C, et al
    Automated model discovery based on COVID-19 epidemiological data from Thuringia, Germany.
    PLoS One. 2026;21:e0344409.
    PubMed         Abstract available
    
    
17. ONYANGO EO, Kiplagat J, Gokiert R, Owuor PM, et al
    An intersectionality-based policy analysis of COVID-19 measures and women informal food vendors in Kisumu, Kenya.
    PLoS One. 2026;21:e0359620.
    PubMed         Abstract available
    
    
18. MESQUITA S, Loureiro J, Haupt Vieira C, Perfeito L, et al
    Learning from pandemics: Feature selection and clustering for robust digital disease nowcasting.
    PLoS One. 2026;21:e0358063.
    PubMed         Abstract available
    
    
19. ABI ZEID B, El Khoury T, Abdulrahim S, Ghattas H, et al
    Predicting COVID-19 infection among older Syrian refugees in Lebanon: A multi-wave survey.
    PLoS One. 2026;21:e0359272.
    PubMed         Abstract available
    
    
20. BOZDECH M
    Rising performance-efficiency demands in female junior tennis: A longitudinal analysis of ITF World Tennis Tour Juniors rankings, 2004-2025.
    PLoS One. 2026;21:e0359538.
    PubMed         Abstract available
    
    
21. JOHNSON G, Edwards S, Jarman H, Peel E, et al
    Understanding delivery of bad news in the emergency department: A scoping review.
    PLoS One. 2026;21:e0358343.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. DUDLEY C, Magdaleno R, Harding C, Sharma A, et al
    Mantis: A foundation model for mechanistic disease forecasting.
    Proc Natl Acad Sci U S A. 2026;123:e2602542123.
    PubMed         Abstract available
    
    

    
    Vaccine

23. NIAN H, Ding T, Lee RL, Gebretsadik T, et al
    COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States.
    Vaccine. 2026;92:129128.
    PubMed         Abstract available
    
    
24. OKHOLM AK, Fougeroux C, Hagen SH, Paludan SR, et al
    Virus-like particle display of the SARS-CoV-2 receptor-binding domain using a modular tag/catcher system enhances immunogenicity of a DNA vaccine in mice.
    Vaccine. 2026;92:129117.
    PubMed         Abstract available
    
    
25. C M, Dymock M, Flanagan KL, Plebanski M, et al
    The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.
    Vaccine. 2026;92:129034.
    PubMed         Abstract available
    
    
26. ONISHI S, Suzuki Y, Sugimoto K, Otsuka A, et al
    Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine.
    Vaccine. 2026;92:129111.
    PubMed         Abstract available
    
    
27. ALMEIDA MG, Alves de Oliveira BF, de Melo Junior EB, de Araujo Rodrigues AR, et al
    Knowledge as a predictor of parental vaccine hesitancy during children's first year of life.
    Vaccine. 2026;92:129127.
    PubMed         Abstract available
    
    
28. DESAI M, Cardona J, Khetan S, Mehta S, et al
    Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine.
    Vaccine. 2026;92:129068.
    PubMed         Abstract available
    
    
29. BLANCHARD C, Myers J, McNabb AL, Lee YA, et al
    Evaluating access to COVID-19 vaccines for children and adolescents in North Carolina through community pharmacies, 2021-2023.
    Vaccine. 2026;92:129125.
    PubMed         Abstract available
    
    
30. FORR A, Salmon DA, Markalanda SH, Joseph A, et al
    Promoting a personalized vaccine information website through social media and local outreach: a dissemination and implementation study.
    Vaccine. 2026;92:129161.
    PubMed         Abstract available
    
    
31. HYDER S, Melchinger H, Malik F, Kuppalli K, et al
    Trust in government institutions and influenza vaccine acceptance among U.S. adults.
    Vaccine. 2026;93:129212.
    PubMed         Abstract available
    
    
32. TSOU TP, Huang YT, Lin CY, Chu PW, et al
    Influenza vaccine effectiveness against influenza-related medical visits, hospitalization and death among adults aged 65 years and older in Taiwan: interim 2024-2025 season result using standard-dose inactivated influenza vaccine.
    Vaccine. 2026;93:129165.
    PubMed         Abstract available
    
    
33. JAYASHANKAR L, DeGrace M, Treanor J, Swanson NJ, et al
    Protection Before Day One: advancing broadly protective seasonal influenza vaccines with pandemic coverage.
    Vaccine. 2026;93:129188.
    PubMed        

#Maternal #vaccination against #COVID19, #influenza, #pertussis, and #RSV: a scoping review

 

Abstract

Pregnancy and early infancy are periods of heightened vulnerability, with SARS-CoV-2 and influenza infections potentially linked to adverse pregnancy outcomes, including preterm birth and stillbirth. Maternal vaccination provides direct protection to mothers by active immunisation
and to infants by passive immunisation. This scoping review mapped and described published literature on maternal vaccination against COVID-19, influenza, pertussis, and respiratory syncytial virus (RSV). It includes information on the outcome domains studied and if timing of vaccination was examined, with the aim of identifying evidence gaps and supporting decision-makers in choosing priority areas for subsequent systematic review topics. A comprehensive literature search across multiple databases of studies published from January 2000 to October 2025 identified 635 publications (540 publications of primary studies, 95 evidence syntheses). Studies on COVID-19 (260 publications of studies, 45 reviews), influenza (161 publications of studies, 29 reviews), pertussis (113 publications of studies, 20 reviews), and RSV (20 publications of studies, 11 reviews) were analysed. Available evidence on COVID-19, influenza, and pertussis vaccination on efficacy, effectiveness, safety and immunogenicity outcomes is considerable. RSV vaccination evidence is limited. Updated systematic reviews would be helpful to clarify the optimal timing of COVID-19 and influenza vaccination and the effectiveness and safety of the coadministration of influenza and pertussis vaccines.

Source: 

Link: https://www.nature.com/articles/s41541-026-01545-2

____

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 26 '26)

 

Arch Virol

1. LEE K, An SH, Heo GB, Lee YJ, et al
   Correction: Genomic characterization of H6N1 avian influenza viruses from wild birds and domestic ducks in the republic of Korea and Mongolia (2022-2024).
   Arch Virol. 2026;171:283.
   PubMed        
   
   

   
   Biochem Soc Trans

2. CAWTHORNE W, Zhang Y, Val N, Nelson M, et al
   Unmasking programmed cell death in rhinovirus-driven asthma pathology.
   Biochem Soc Trans. 2026;54:1359-1373.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. SU L, Chen HS, Qiu WL, Zhong WM, et al
   The rationality of drug treatment and clinical characteristics in children with SARS-CoV-2 infection: a retrospective analysis.
   BMC Pediatr. 2026;26:894.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

4. MITCHELL E, Zhu H, Fitzpatrick T, Majoe A, et al
   Social disparities and the COVID-19, influenza, and RSV 'tripledemic' in Ontario, Canada: A population-based study.
   Epidemiol Infect. 2026;154:e117.
   PubMed         Abstract available
   
   

   
   Eur J Epidemiol

5. ANDREASSON J, Bennet L, Bjork J, Dietler D, et al
   SARS-CoV-2 infection as a trigger of type 2 diabetes in adults: a population-based cohort study in Sweden using a double negative control design.
   Eur J Epidemiol. 2026;41:959-967.
   PubMed         Abstract available
   
   
6. HELLE S, Tanskanen AO, Danielsbacka M
   The decade of double-trouble: live birth and stillbirth sex ratio variation in Finland during the COVID-19 pandemic and Russia's attack on Ukraine.
   Eur J Epidemiol. 2026;41:1019-1028.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. SCHUMER C, Mann AJ, Fourati S, Lukas P, et al
   Viral Dynamics of the Respiratory Syncytial Virus During Experimental Human Challenge: Implication for Transmission and Protection.
   J Infect Dis. 2026;234:407-416.
   PubMed         Abstract available
   
   
8. ALKARKOUKLY S, Hambo S, Menk M, Spieth P, et al
   Regulatory T-Cell Notch4 Expression Correlates With Mortality in Patients Hospitalized With COVID-19.
   J Infect Dis. 2026;234:396-406.
   PubMed         Abstract available
   
   
9. ENGELMANN I, Pisoni A, Mille C, Ayadi M, et al
   Age-Dependent Clinical and Molecular Rhinovirus Epidemiology, 2018-2023.
   J Infect Dis. 2026;234:417-426.
   PubMed         Abstract available
   
   
10. MCCULLOCH DJ, Khawaja F, Tverdek FP, Ford ES, et al
    First Report on Remdesivir Use for the Treatment of Respiratory Syncytial Virus in Five Allogeneic Hematopoietic Cell Transplant Recipients.
    J Infect Dis. 2026;234:e552-e555.
    PubMed         Abstract available
    
    
11. MARCHAL A, Kerdiles T, Perrin A, Gervais A, et al
    High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.
    J Infect Dis. 2026;234:e515-e521.
    PubMed         Abstract available
    
    
12. ROEN AO, Hedberg P, Pereira JPV, Zazzi M, et al
    Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project.
    J Infect Dis. 2026;234:e496-e505.
    PubMed         Abstract available
    
    
13. FREYN AW, Budigi Y, Girard B, Santos G, et al
    Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.
    J Infect Dis. 2026 Jun 4:jiag248. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

14. ZHANG L, Chen N, Eichmann A, Nehlmeier I, et al
    The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.
    J Virol. 2026 Aug 5:e0069126. doi: 10.1128/jvi.00691.
    PubMed         Abstract available
    
    
15. RIOS CARRASCO M, Guerreiro Cabana MF, Kovacs E, Ducarne Z, et al
    Acquisition of specific human respiratory tract binding by 2.3.4.4b H5N1 hemagglutinins requires multiple mutations.
    J Virol. 2026;100:e0106526.
    PubMed         Abstract available
    
    
16. KUMAR S, Lai L, Ellis ML, Patel A, et al
    Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.
    J Virol. 2026 Aug 26:e0074926. doi: 10.1128/jvi.00749.
    PubMed         Abstract available
    
    
17. STADLER E, Mordant F, Gartner M, Docken SS, et al
    Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays.
    J Virol. 2026 Aug 27:e0082326. doi: 10.1128/jvi.00823.
    PubMed         Abstract available
    
    
18. LIU G, Chen J, Wu F, Wei P, et al
    Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects.
    J Virol. 2026 Aug 28:e0059926. doi: 10.1128/jvi.00599.
    PubMed         Abstract available
    
    
19. XIE E, Schubert M, Reeb J, Seligmann B, et al
    Arp2/3 complex-dependent actin remodeling is required for efficient RSV uncoating in A549 cells.
    J Virol. 2026;100:e0111726.
    PubMed         Abstract available
    
    
20. ULLAH R, Chen W, Zhang L, Guo C, et al
    Interaction between DEAD-box RNA helicase 10 and influenza PB1 polymerase selectively regulates influenza A virus replication.
    J Virol. 2026 Sep 22:e0081526. doi: 10.1128/jvi.00815.
    PubMed         Abstract available
    
    
21. LEMUS-REYES JI, Fernandez-Quintero ML, Ayala E, Swanson OM, et al
    Antigenic and structural analysis of the influenza hemagglutinin lateral patch.
    J Virol. 2026 Sep 23:e0126526. doi: 10.1128/jvi.01265.
    PubMed         Abstract available
    
    
22. PARK H-S, Matsuoka Y, Santos C, Duncan EF, et al
    Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters.
    J Virol. 2026 Sep 24:e0093826. doi: 10.1128/jvi.00938.
    PubMed         Abstract available
    
    

    
    PLoS One

23. SODERSTROM LINDSTROM H, Norstrom SH, Tang C, Lindberg RH, et al
    Occurrence of influenza antivirals and resistance development in influenza A viruses in aquatic environments: A risk assessment.
    PLoS One. 2026;21:e0358447.
    PubMed         Abstract available
    
    
24. OHLSON A, Rehn M, Kuhlmann Berenzon S, Sturegard E, et al
    Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023-2024.
    PLoS One. 2026;21:e0358326.
    PubMed         Abstract available
    
    
25. VAN KOEVERING K, Hong Y, Kleinberg J
    Social tectonics: Rapid organization of online COVID communities.
    PLoS One. 2026;21:e0355369.
    PubMed         Abstract available
    
    
26. VARGA C
    Spatiotemporal clustering of highly pathogenic avian influenza (HPAI) H5N1 at the wild waterfowl-poultry interface: Vector-specific spillover risks in the U.S., 2022-2025.
    PLoS One. 2026;21:e0345354.
    PubMed         Abstract available
    
    
27. ZHANG Y, Zhang Y, Zhao C, Xu X, et al
    Quantitative assessment of china's policies on the online sale of prescription drugs.
    PLoS One. 2026;21:e0358484.
    PubMed         Abstract available
    
    
28. AICHBERGER MC, Fetz K, Leong S, Kim HS, et al
    Discrimination and technology-based disease control.
    PLoS One. 2026;21:e0357004.
    PubMed         Abstract available
    
    
29. FERNANDEZ-PINEDA M, Swift A, Dolbier C, Swanson M, et al
    Navigating grief and healthcare: Mixed-methods study on patient experiences of miscarriage during COVID-19.
    PLoS One. 2026;21:e0359158.
    PubMed         Abstract available
    
    
30. BIR C, Widmar NO, Wolf CA, Sheridan T, et al
    Societal values versus individual rights with respect to public health related practices during the COVID-19 pandemic in the U.S.
    PLoS One. 2026;21:e0358741.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. MAROUGKA K, Leiva-Rebollo R, Hofma F, van Dijk A, et al
    Substitutions affecting the HA-NA-receptor balance preceded the emergence of the pandemic 2009 H1N1 virus.
    Proc Natl Acad Sci U S A. 2026;123:e2609870123.
    PubMed         Abstract available
    
    

    
    Vaccine

32. SCHAFFNER W, Gravenstein S, Kissler S, Cornely OA, et al
    Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.
    Vaccine. 2026;93:129082.
    PubMed         Abstract available
    
    

    
    Virology

33. ROWE T, Ross TM
    Transcriptional decoupling of the epithelial-immune bridge is associated with suboptimal influenza B virus immunogenicity.
    Virology. 2026;625:111075.
    PubMed         Abstract available
    
    

    
    Virus Res

34. WU Q, Wang ZZ, Wang ZM, Wang YH, et al
    Development and validation of a broadly cross-reactive polyclonal antibody as capture antibody for pan human beta coronavirus antigen detection.
    Virus Res. 2026;372:199786.
    PubMed         Abstract available
    
    
35. MANEESRIWONGUL W, Deesamer S, Butsing N
    Factors influencing Thai parents' COVID-19 vaccine acceptance for their children: Vaccine attitudes, beliefs, and children's past influenza vaccination.
    Virus Res. 2026 Sep 20:199805. doi: 10.1016/j.virusres.2026.199805.
    PubMed         Abstract available
    
    
36. JANG Y, Cha RM, Park MJ, Kim JM, et al
    Genetic Diversity of Clade 2.3.4.4b H5Nx High Pathogenicity Avian Influenza Viruses Detected in Korea During the 2025-2026 Winter Season and Pathogenicity of H5N1 and H5N9 Viruses.
    Virus Res. 2026 Sep 22:199807. doi: 10.1016/j.virusres.2026.199807.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 19 '26)

 

Arch Virol

1. SEO H, Rauf A, Seo SH
   Enhanced induction of inflammatory cytokines in human lung cells infected with highly pathogenic recent H5N1/2024 avian influenza virus.
   Arch Virol. 2026;171:278.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. MAITITUERSUN Y, Su R, Yang G, Taerken AY, et al
   A longitudinal study on differential impacts of the COVID-19 pandemic and normalized prevention and control on overweight and obese adolescents in China.
   BMC Pediatr. 2026;26:882.
   PubMed         Abstract available
   
   
3. O'SHEA TM, McGrath M, Douglas J, Blackwell CK, et al
   Child health-related behaviors, social connectedness, and impact of the COVID-19 pandemic on children born preterm in the ECHO Cohort.
   BMC Pediatr. 2026 Jul 20. doi: 10.1186/s12887-026-07337.
   PubMed         Abstract available
   
   

   
   Cell

4. WU Q, Seydlitz LM, Iakimov V, Hsu DJ, et al
   Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection.
   Cell. 2026;189:6012-6023.
   PubMed         Abstract available
   
   

   
   Eur J Epidemiol

5. KOSTER EAS, Sluiskes MH, Putter H, Rosendaal FR, et al
   Dynamics of infection, vaccination and excess mortality during the COVID-19 pandemic among older individuals-a nationwide analysis.
   Eur J Epidemiol. 2026;41:869-880.
   PubMed         Abstract available
   
   
6. LEHNER CT, Anastasova I, Schauberger G, Eberl M, et al
   Increasing incidence of type 1 diabetes in children and adolescents from 2012 to 2021 in Germany: trends before and during the COVID-19 pandemic.
   Eur J Epidemiol. 2026;41:881-892.
   PubMed         Abstract available
   
   

   
   J Gen Virol

7. ROSS RA, Walsh SK, Montgomery H, Chen H, et al
   Bovine mammary tissues are susceptible to infection by viruses bearing panzootic H5N1 influenza A virus glycoproteins.
   J Gen Virol. 2026;107:002338.
   PubMed         Abstract available
   
   

   
   J Infect

8. HARRIS R, Thirard R, Iftikhar H, Middleditch A, et al
   Corrigendum to "Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: A randomised controlled trial" [J Infect 93 (2026) 106784].
   J Infect. 2026;93:106853.
   PubMed        
   
   

   
   PLoS Biol

9. VALENCA-PEREIRA F, Johnson B, DeGregori J, Rincon M, et al
   Does acute inflammation triggered by infection promote cancer progression?
   PLoS Biol. 2026;24:e3003962.
   PubMed         Abstract available
   
   

   
   PLoS Comput Biol

10. D'AVANZO M, Myint AP, Cacciapaglia G, Hohenegger S, et al
    From sequences to strategies: Early detection of new SARS-CoV-2 variants via genetic distance to reduce hospitalizations.
    PLoS Comput Biol. 2026;22:e1014707.
    PubMed         Abstract available
    
    

    
    PLoS One

11. YANG SL, Liu MT, Huang HH, Lin SW, et al
    Epidemiology of human RSV in Taiwan, 2018-2024.
    PLoS One. 2026;21:e0357769.
    PubMed         Abstract available
    
    
12. WOLSKO C, Marino E
    Incorporating public values into public health communications: Effects of value affirmations on intentions to vaccinate and trust in the U.S.
    PLoS One. 2026;21:e0356783.
    PubMed         Abstract available
    
    
13. FUENTES K, Jacobson D, Birze A, Cadel L, et al
    Building capacity in health systems with and for caregivers: A photovoice protocol.
    PLoS One. 2026;21:e0358550.
    PubMed         Abstract available
    
    
14. LI Q, Tang Y, Shi Y, Wu Y, et al
    Census-based adolescent depression risk assessment: A novel method and reflections.
    PLoS One. 2026;21:e0357661.
    PubMed         Abstract available
    
    
15. VENKATESAN S, White L, Koo HN, Dickerson J, et al
    Estimating cumulative incidence from partially missing time series of respiratory viral infections.
    PLoS One. 2026;21:e0353681.
    PubMed         Abstract available
    
    
16. AKTAS N, Ersoy A, Oruc A, Ortac H, et al
    Attitudes, perceptions, behaviours, and concerns of patients listed for kidney transplantation during the COVID-19 pandemic.
    PLoS One. 2026;21:e0358328.
    PubMed         Abstract available
    
    
17. AL-MAGABLEH M, Muhaisen AHM, Ateir RM, Abu Eraq SA, et al
    Herbal or conventional medicine? A cross-sectional study of Jordanian university students' preferences for cold and flu treatment.
    PLoS One. 2026;21:e0358179.
    PubMed         Abstract available
    
    
18. SUERDEM A, Zdravkov S, Ivanov MJ
    Beyond deficit and coexistence: Modeling the knowledge-conspiracy-mistrust configuration in public understanding of science.
    PLoS One. 2026;21:e0341946.
    PubMed         Abstract available
    
    
19. GWANZURA TNR, Trepka MJ, Li T, Juhasz L, et al
    COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study.
    PLoS One. 2026;21:e0358543.
    PubMed         Abstract available
    
    
20. DE VERAS BMG, Michelin L, Croda J, Berra TZ, et al
    Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024).
    PLoS One. 2026;21:e0357303.
    PubMed         Abstract available
    
    

    
    Vaccine

21. HOEN L, Lartey S, Pathirana RD, Cox RJ, et al
    Elucidating the role of pre-existing immunity in mucosal lymphoid architectural dynamics following live attenuated influenza vaccination.
    Vaccine. 2026;92:129139.
    PubMed         Abstract available
    
    
22. GUO J, Dai C, Huang Y, Dai J, et al
    Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys.
    Vaccine. 2026;92:129137.
    PubMed         Abstract available
    
    
23. LAOHARATTANAHIRUN N, Kiertiburanakul S, Boonnak K, Bruminhent J, et al
    Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial.
    Vaccine. 2026;92:129166.
    PubMed         Abstract available
    
    
24. OSTROWSKY JT, Gellin BG, Cavaleri M, Bresee JS, et al
    Innovation, development, and licensure of improved influenza vaccines: the way forward.
    Vaccine. 2026;92:129135.
    PubMed         Abstract available
    
    
25. ZHOU B, Wang J, Knote C
    Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression.
    Vaccine. 2026;92:129163.
    PubMed         Abstract available